Hepatitis B surface antigen (HBsAg) prevalence (%) in Togo
Togo: Hepatitis B surface antigen (HBsAg) prevalence was 1.4% in 2024. ▼ Falling
Latest (2024)
1.4%
Change on year
down 6.7%
World rank
19th
of 194 countries
All-time high
2.0%
in 2015
All-time low
1.4%
in 2024
Years of data
10
2015–2024
Hepatitis B surface antigen (HBsAg) prevalence in Togo, 2015–2024
Source: World Health Organization, Global Health Observatory.
Analysis
Togo recorded 1.4% for hepatitis b surface antigen (hbsag) prevalence in 2024. That is the lowest value across all 10 years on record.
That represents a change of down 6.7% on the previous year and down 30.0% over ten years.
Over the whole period, hepatitis b surface antigen (hbsag) prevalence in Togo peaked at 2.0% in 2015 and was at its lowest, 1.4%, in 2024.
Togo ranks 19th of 194 countries on this measure, in the top 10%.
Hepatitis B surface antigen (HBsAg) prevalence in Togo, year by year
| Year | Value | Change |
|---|---|---|
| 2015 | 2.0% | — |
| 2016 | 2.0% | +0.0% |
| 2017 | 2.0% | +0.0% |
| 2018 | 1.9% | -5.0% |
| 2019 | 1.7% | -10.5% |
| 2020 | 1.7% | +0.0% |
| 2021 | 1.6% | -5.9% |
| 2022 | 1.5% | -6.3% |
| 2023 | 1.5% | +0.0% |
| 2024 | 1.4% | -6.7% |
Togo compared with similar countries
- Togo's 1.4% is above the median for lower middle income countries, which is 0.6%, 2.3× the median. (47 countries reporting)
- Togo's 1.4% is above the median for Sub-Saharan Africa, which is 1.1%, 1.3× the median. (48 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 1.9% | 1.7% | 2.0% | 5 |
| 2020s | 1.5% | 1.4% | 1.7% | 5 |
Countries ranked near Togo
- 17 South Sudan 1.7% compare
- 18 Congo 1.6% compare
- 19 Solomon Islands 1.4% compare
- 19 Democratic Republic of Congo 1.4% compare
- 19 Lesotho 1.4% compare
- 19 Mauritania 1.4% compare
More health data for Togo
- Un projection of annual infant deaths, annual growth rate -1.03 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.7948 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 875 deaths per 1,000 people (2090)
- Number of infants who die before age 1 5,021 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 4 (2025)
- Population ages 00-04, female, annual growth rate 2.86 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0681 units per person (2025)
- Population ages 00-04, male, annual growth rate 2.37 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0.0001 units per US$ of GDP (2025)
Frequently asked questions
- What is hepatitis b surface antigen (hbsag) prevalence in Togo?
- Hepatitis b surface antigen (hbsag) prevalence in Togo was 1.4% in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest hepatitis b surface antigen (hbsag) prevalence recorded in Togo?
- The highest recorded value was 2.0% in 2015.
- What is the lowest hepatitis b surface antigen (hbsag) prevalence recorded in Togo?
- The lowest recorded value was 1.4% in 2024.
- How does Togo rank for hepatitis b surface antigen (hbsag) prevalence?
- Togo ranks 19th out of 194 countries with data for 2024.
- Is hepatitis b surface antigen (hbsag) prevalence rising or falling in Togo?
- Over the last ten years it is down 30.0%. The long-run trend across the full record is falling.
- Where does this Togo data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 10 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).